Commentary: Microbial panaceas: does development have the answer? - reflections on Cowan, Dinan, & Cryan (2020)

Area of Science:

• Neuroscience
• Microbiology
• Developmental Biology

Background:

• The gut microbiome's role in neurodevelopmental disorders (NDDs) is under investigation.
• Current research explores the microbiome as a potential therapeutic target for NDDs.
• Translating microbiome research into clinical practice for NDDs is premature.

Purpose of the Study:

• To critically evaluate the microbiome's current standing as a treatment adjunct for NDDs.
• To assess whether the microbiome is a viable panacea or a distraction from established treatments.
• To determine the optimal approach for understanding and potentially utilizing microbiome data in NDDs.

Main Methods:

• Review of existing scientific literature on the microbiome and NDDs.
• Analysis of data through a developmental lens.
• Assessment of the readiness of the field for clinical translation.

Main Results:

• The microbiome's precise role in NDDs remains unclear.
• Evidence does not yet support the microbiome as a panacea for NDDs.
• A developmental perspective is crucial for interpreting microbiome data.

Conclusions:

• The microbiome is not a current panacea for neurodevelopmental disorders.
• A developmental approach is essential for understanding the microbiome's influence on NDDs.
• Clinical translation of microbiome-based therapies for NDDs requires further research and caution.